William Malcolm

Czechoslovak Group Buys Stake In Prague Fertility Centre

Jaroslav Strnad’s Czechoslovak Group (CSG) has acquired a stake in the Prague Fertility Centre, a leading innovator in infertility treatment. CSG bought the shares from the center’s co-founder, Dr. Sonja Lazarovská. Financial terms were not disclosed. The centre founded in 2009, has delivered over 5,000 babies.

“We perceive the acquisition as an interesting investment opportunity, and we perceive the co-ownership of the center as a long-term project. However, CSG’s primary business area will remain industry,” Petr Formánek, Head of Corporate Finance at CSG.

The Prague Fertility Center conducts its own research in the field of embryology. Research and innovation focus on monitoring and evaluating embryo vitality in the early stages of development, leading to the selection of embryos suitable for biopsy, which increases the likelihood of success in assisted reproduction. Artificial intelligence helps the center’s staff in evaluating embryos.

“Innovations have been and will be, together with quality care for our clients, the central part of the story that the Prague Fertility Center has been writing for over thirty years. In order to realize our plans, funds are needed to help us take our services a step further. I believe we have found him in the CSG group, “says Sonja Lazarovská.

Dr. Sonja Lazarovská, an obstetrician-gynecologist, cofounded the Prague Fertility Center together with clinical embryologist Daniel Hlinka. Who transferred his share to Medical Solutions this year. In the centre, they both act as executives. They lead an experienced team of doctors and embryologists. The Prague Fertility Centre is located in Prague in the Hospital with a polyclinic in Vysočany.

The Czechoslovak Group’s companies operate in the automotive, railway, aerospace, and watchmaking industries and manufacture weapons, ammunition, and special vehicles.

The companies included in the CSG holding generated revenues over CZK 28.5 billion in 2019 and have more than 8,200 employees.

Hartenberg Capital, which manages the assets of Prime Minister Andrej Babiš, is also very active in the field of artificial reproduction. The fund invested in the healthcare business by purchasing several fertility clinics and also owns a majority stake in the Modřany Polyclinic. Hartenberg has also made investments in biotechnology and the food industry.